These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12050096)

  • 21. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of early-onset baldness to prostate cancer in African-American men.
    Zeigler-Johnson C; Morales KH; Spangler E; Chang BL; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):589-96. PubMed ID: 23532004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body size and composition and prostate cancer risk.
    MacInnis RJ; English DR; Gertig DM; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1417-21. PubMed ID: 14693731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Height, urban-born and prostate cancer risk in Japanese men.
    Minami Y; Tochigi T; Kawamura S; Tateno H; Hoshi S; Nishino Y; Kuwahara M
    Jpn J Clin Oncol; 2008 Mar; 38(3):205-13. PubMed ID: 18272473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Male pattern baldness is not associated with established cardiovascular risk factors in the general population.
    Ellis JA; Stebbing M; Harrap SB
    Clin Sci (Lond); 2001 Apr; 100(4):401-4. PubMed ID: 11256978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study.
    Kopec JA; Goel V; Bunting PS; Neuman J; Sayre EC; Warde P; Levers P; Fleshner N
    J Urol; 2005 Aug; 174(2):495-9; discussion 499. PubMed ID: 16006879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for prostate cancer in men aged less than 60 years: a case-control study from Italy.
    Gallus S; Foschi R; Talamini R; Altieri A; Negri E; Franceschi S; Montella M; Dal Maso L; Ramazzotti V; La Vecchia C
    Urology; 2007 Dec; 70(6):1121-6. PubMed ID: 18158031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could mining be protective against prostate cancer? A study and literature review.
    Girschik J; Glass D; Ambrosini GL; Fritschi L
    Occup Environ Med; 2010 Jun; 67(6):365-74. PubMed ID: 19819854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
    Lis-Święty A; Arasiewicz H; Ranosz-Janicka I; Brzezińska-Wcisło L
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1815-1818. PubMed ID: 29237093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer.
    Platz EA; De Marzo AM; Erlinger TP; Rifai N; Visvanathan K; Hoffman SC; Helzlsouer KJ
    Prostate; 2004 Jun; 59(4):393-400. PubMed ID: 15065087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.
    Severi G; Hayes VM; Padilla EJ; English DR; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):610-2. PubMed ID: 17372260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
    Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
    J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans.
    Thomas JA; Antonelli JA; Banez LL; Hoyo C; Grant D; Demark-Wahnefried W; Platz EA; Gerber L; Shuler K; Eyoh E; Calloway E; Freedland SJ
    Cancer Causes Control; 2013 May; 24(5):1045-52. PubMed ID: 23529469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer and vasectomy: a hospital-based case-control study in China, Nepal and the Republic of Korea.
    Schwingl PJ; Meirik O; Kapp N; Farley TM;
    Contraception; 2009 May; 79(5):363-8. PubMed ID: 19341848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.
    Cremers RG; Aben KK; Vermeulen SH; den Heijer M; van Oort IM; Kiemeney LA
    Eur J Cancer; 2010 Dec; 46(18):3294-9. PubMed ID: 20561779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and the risk of prostate cancer.
    Porter MP; Stanford JL
    Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgenetic alopecia and coronary artery disease in women.
    Mansouri P; Mortazavi M; Eslami M; Mazinani M
    Dermatol Online J; 2005 Dec; 11(3):2. PubMed ID: 16409898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer.
    Rosenblatt KA; Carter JJ; Iwasaki LM; Galloway DA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):763-8. PubMed ID: 12917208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.